A detailed history of Azzad Asset Management Inc /Adv transactions in Merck & Co., Inc. stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 44,373 shares of MRK stock, worth $4.36 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
44,373
Previous 43,770 1.38%
Holding current value
$4.36 Million
Previous $5.42 Billion 7.01%
% of portfolio
0.57%
Previous 0.64%

Shares

49 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$111.15 - $128.97 $67,023 - $77,768
603 Added 1.38%
44,373 $5.04 Billion
Q2 2024

Jul 30, 2024

SELL
$123.8 - $132.96 $1.93 Million - $2.08 Million
-15,614 Reduced 26.29%
43,770 $5.42 Billion
Q1 2024

Apr 19, 2024

BUY
$113.24 - $131.95 $121,166 - $141,186
1,070 Added 1.83%
59,384 $7.84 Billion
Q4 2023

Apr 01, 2024

BUY
$100.18 - $109.02 $8,314 - $9,048
83 Added 0.14%
58,314 $6.36 Billion
Q3 2023

Apr 01, 2024

BUY
$102.95 - $114.33 $400,063 - $444,286
3,886 Added 7.15%
58,231 $5.99 Billion
Q2 2023

Apr 01, 2024

SELL
$108.61 - $118.38 $653,723 - $712,529
-6,019 Reduced 9.97%
54,345 $6.27 Billion
Q1 2023

Apr 01, 2024

SELL
$102.94 - $114.86 $510,891 - $570,050
-4,963 Reduced 7.6%
60,364 $6.42 Billion
Q4 2022

Apr 01, 2024

SELL
$87.44 - $112.11 $1.33 Million - $1.71 Million
-15,234 Reduced 18.91%
65,327 $7.25 Billion
Q3 2022

Apr 01, 2024

SELL
$84.53 - $94.96 $785,790 - $882,748
-9,296 Reduced 10.35%
80,561 $6.8 Billion
Q2 2022

Apr 01, 2024

BUY
$83.49 - $94.64 $1.62 Million - $1.84 Million
19,399 Added 27.53%
89,857 $7.97 Billion
Q1 2022

Apr 01, 2024

BUY
$73.51 - $82.4 $507,880 - $569,301
6,909 Added 10.87%
70,458 $5.78 Billion
Q4 2021

Apr 01, 2024

SELL
$72.28 - $90.54 $13,733 - $17,202
-190 Reduced 0.3%
63,549 $4.87 Billion
Q3 2021

Apr 01, 2024

BUY
$71.68 - $78.83 $410,224 - $451,144
5,723 Added 9.86%
63,739 $4.79 Billion
Q2 2021

Apr 01, 2024

BUY
$70.31 - $77.77 $2.28 Million - $2.52 Million
32,363 Added 126.16%
58,016 $4.51 Billion
Q1 2021

Apr 01, 2024

BUY
$68.86 - $81.11 $201,415 - $237,246
2,925 Added 12.87%
25,653 $1.98 Billion
Q4 2020

Apr 01, 2024

BUY
$71.77 - $79.65 $416,768 - $462,527
5,807 Added 34.32%
22,728 $1.86 Billion
Q3 2020

Apr 01, 2024

BUY
$73.18 - $82.95 $54,445 - $61,714
744 Added 4.6%
16,921 $1.4 Billion
Q2 2020

Apr 01, 2024

SELL
$70.42 - $80.13 $29,294 - $33,334
-416 Reduced 2.51%
16,177 $1.25 Billion
Q1 2020

Apr 01, 2024

SELL
$63.36 - $87.82 $1.01 Million - $1.4 Million
-15,909 Reduced 48.95%
16,593 $1.28 Billion
Q4 2019

Apr 01, 2024

BUY
$77.58 - $87.54 $13,033 - $14,706
168 Added 0.52%
32,502 $2.74 Billion
Q3 2019

Apr 01, 2024

BUY
$76.08 - $82.93 $1.24 Million - $1.35 Million
16,333 Added 102.07%
32,334 $2.61 Billion
Q2 2019

Apr 01, 2024

SELL
$69.84 - $81.59 $40,786 - $47,648
-584 Reduced 3.52%
16,001 $1.34 Billion
Q1 2019

Apr 01, 2024

SELL
$69.58 - $79.36 $11,828 - $13,491
-170 Reduced 1.01%
16,585 $1.38 Billion
Q4 2018

Apr 01, 2024

SELL
$65.24 - $75.71 $68,762 - $79,798
-1,054 Reduced 5.92%
16,755 $1.28 Billion
Q3 2018

Apr 01, 2024

BUY
$57.69 - $67.84 $94,265 - $110,850
1,634 Added 10.1%
17,809 $1.26 Billion
Q2 2018

Apr 01, 2024

BUY
$50.83 - $59.72 $822,175 - $965,971
16,175 New
16,175 $982 Million
Q1 2018

Apr 03, 2024

SELL
$50.96 - $59.23 $359,624 - $417,986
-7,057 Reduced 30.04%
16,437 $895 Million
Q4 2017

Apr 03, 2024

BUY
$51.62 - $61.64 $202,040 - $241,258
3,914 Added 19.99%
23,494 $1.32 Billion
Q3 2017

Apr 03, 2024

BUY
$58.67 - $63.13 $36,375 - $39,140
620 Added 3.27%
19,580 $1.25 Billion
Q2 2017

Apr 03, 2024

BUY
N/A
1,052 Added 5.87%
18,960 $1.22 Billion
Q1 2017

Apr 03, 2024

BUY
N/A
828 Added 4.85%
17,908 $1.14 Billion
Q4 2016

Apr 03, 2024

BUY
N/A
715 Added 4.37%
17,080 $1.01 Billion
Q3 2016

Apr 03, 2024

BUY
N/A
2,698 Added 19.74%
16,365 $1.02 Billion
Q2 2016

Apr 03, 2024

BUY
N/A
777 Added 6.03%
13,667 $787 Million
Q1 2016

Apr 03, 2024

BUY
N/A
1,144 Added 9.74%
12,890 $682 Million
Q4 2015

Apr 03, 2024

BUY
N/A
4,939 Added 72.56%
11,746 $620 Million
Q3 2015

Apr 03, 2024

BUY
N/A
423 Added 6.63%
6,807 $336 Million
Q2 2015

Apr 03, 2024

SELL
N/A
-30 Reduced 0.47%
6,384 $363 Million
Q1 2015

Apr 03, 2024

BUY
N/A
321 Added 5.27%
6,414 $369 Million
Q4 2014

Apr 03, 2024

BUY
N/A
351 Added 6.11%
6,093 $346 Million
Q3 2014

Apr 03, 2024

BUY
N/A
220 Added 3.98%
5,742 $340 Million
Q2 2014

Apr 03, 2024

BUY
N/A
60 Added 1.1%
5,522 $319 Million
Q1 2014

Apr 03, 2024

BUY
N/A
277 Added 5.34%
5,462 $310 Million
Q4 2013

Apr 03, 2024

BUY
N/A
270 Added 5.49%
5,185 $260 Million
Q2 2013

Apr 03, 2024

BUY
N/A
168 Added 3.54%
4,915 $234 Million
Q1 2013

Apr 03, 2024

SELL
N/A
-53,567 Reduced 91.86%
4,747 $210 Million
Q2 2011

Apr 08, 2024

SELL
N/A
-7,365 Closed
0 $0
Q1 2011

Apr 08, 2024

SELL
N/A
-901 Reduced 10.9%
7,365 $243 Million
Q4 2010

Apr 08, 2024

SELL
N/A
-50,048
8,266 $298 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Azzad Asset Management Inc /Adv Portfolio

Follow Azzad Asset Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.